김 상 욱 (SANG WOOK KIM , M.D., PhD)
PERSONAL INFORMATION:
Name: Sang Wook Kim
Position: Professo
Affiliation: Department of Internal Medicine
Jeonbuk National University Hospital
20 Geonji-ro, Deokjin-gu, 54907, KOREA
Phone: (82) 63-250- 2302
FAX: (82) 63-254- 1609
C.P: (82) 010-9216-7915
E-mail: clickm@jbnu.ac.kr
EDUCATION/TRAINING:
2005: PhD. Chonbuk National University Postgraduate School, Jeonju, Korea
2001: M.S., College of Medicine, Wonkwang University, Iksan, Korea
1994: M.D., College of Medicine, Wonkwang University, Iksan, Korea
|
|
|
MEDICAL LICENSES AND BOARD CERTIFICATIONS:
1994 Board Member, Korean Medical Association
2002 Board Member, The Korean Association of Internal Medicine
2003 Board Member, The Korean Society of Gastrointestinal Edoscopy
2004 Board Member, The Korean Society of Gastroenterology
Professional Experience:
|
2002-2003 |
Fellow Instructor, Department of Internal Medicine, College of Medicine, Wonkwang University (Hospital) |
|
2003-2004 |
Lecturer (Tenure-track), Department of Internal Medicine, College of Medicine, Wonkwang University (Hospital) |
|
2004-2005 |
Lecturer (Tenure-track), Department of Internal Medicine, Chonbuk National University Medical School & Hospital, Jeonju, Korea |
|
2005-2009 |
Assistant Professor, Department of Internal Medicine, Chonbuk National University Medical School & Hospital, Jeonju, Korea |
|
2007-2009 |
Visiting Faculty, Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas |
|
2009-2014 |
Associate Professor, Department of Internal Medicine, Chonbuk National University Medical School & Hospital, Jeonju, Korea |
2014-Present Professor, Department of Internal Medicine, Chonbuk Naional University Medical School & Hospital, Jeonju, Korea
Research Interests:
Development of Molecular Therapy
Development of Colorectal cancer mechanism
Development of Therapeutic materials of Colorectal cancer
Kim SL, La MT, Shin MW, Kim HK, Kim SW. A novel HDAC1 inhibitor, CBUD-1001, exerts andicancer effects by modulating the apoptosis and EMT of colorectal cancer cells. Internal Journal of Oncology 2020:57:1027-1038.
Lee CK, Ha HJ, Oh SJ,Kim JW, Lee JK, Kim HS, Yoon SM, Kang SB, Kim ES, Kim TO, Na SY, Lee J, Kim SW, et al. Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database. Journal of Gastroenterology and Hepatology 2020:35:760-768.
Park YR, Lee ST, Kim SL, Zhu SM, Lee MR, Kim SH, Kim IH, Lee SO, Seo SY, Kim SW. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Cancer Genet 2019:231-232:22-31.
Jung JS, Hong JY, Oh HH, Kweon SS, Lee J, Kim SW, Seo GS, Kim HS, Joo YE. Clinical outcomes of endoscopic resection for colorectal laterally spreading tumors with advance histology. Sur Endosc 2019;33:2562-2571.
Zhu SM, Park YR, Seo SY, Kim IH, Lee ST, Kim SW. Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells. Intest Res 2019;17:527-536.
Kim KH, Kim KO, Jung Y, Lee J, Kim SW, Kim JH, Kim TJ, Cho YS, Joo YE. Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: A Korean Association for the Study of Intestinal Diseases (KASID) multicenter study. Sci Rep 2019;8:9:3946.
Son DJ, Kweon SS, Lee J, Kim SW, Seo GS, Kim HS, Joo YE. Risk factors associated with clinical outcomes of endoscopic mucosal resection for colorectal laterally spreading tumors: A Honam Association for the Study of Intestinal Diseases (HASID) multicenter study. Turk J Gastroenterol 2019;30:350-356.
Min IS, Lee CH, Shin IS, Lee NE, Son HS, Kim SB, Seo SY, Kim SH, Kim SW, Lee SO, Lee ST, Kim IH. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate. Gut Liver. 2019 Jan 15;13(1):93-103.
Kim SL, Min IS, Park YR, Lee ST, Kim SW. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer. Int J Oncol 2018;53:2789-2799.
Park YR, Seo SY, Kim SL, Zhu SM, Chun S, Oh JM, Lee MR, Kim SH, Kim IH, Lee SO, Lee ST, Kim SW. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1. Biosci Rep. 2018 Sep 19;38(5).
Kim JH, Lee MJ, Yu GR, Kim SW, Jang KY, Yu HC, Cho BH, Kim DG. Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer. Exp Mol Med. 2018 6;50(4):3.
Kim SL, Park YR, Lee ST, Kim SW. Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer. Int J Oncol. 2017 ;51(6):1809-1820.
Yim SK, Kim SW. Refractory Irritable Bowel Syndrome and Functional Abdominal Pain Syndrome: Should Small Bowel Endoscopy Be Performed? Clin Endosc. 2018 ;51(6):508-509.
Myung DS, Kweon SS, Lee J, Shin IS, Kim SW, Seo GS, Kim HS, Joo YE. Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID). PLoS One. 2017 4;12(10):e0184205.
Liu YC, Park YR, Kim SL, Lee ST, Kim SW. MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor. Dig Dis Sci. 2017 ;62(11):3040-3049.
Kim SL, Lee ST, Min IS, Park YR, Lee JH, Kim DG, Kim SW. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer. 2017 108(11):2176-2186.
Kim SW, Moon WS. Iatrogenic Gastric Pseudolipomatosis during Endoscopic Submucosal Dissection. J Pathol Transl Med. 2017 51(5):513-515.
Park YR, Kim SL, Lee MR, Seo SY, Lee JH, Kim SH, Kim IH, Lee SO, Lee ST, Kim SW. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer. J Cancer Res Clin Oncol. 2017 143(10):1915-1927.
Liu YC, Kim SL, Park YR, Lee ST, Kim SW. Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells. Intest Res. 2017 15(2):174-181.
Kim SW. The Role of MicroRNAs in Colorectal Cancer. Korean J Gastroenterol. 2017 25;69(4):206-211.
Lee CH, Kim IH, Moon JC, Seo SY, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Yang JD, Yu HC. 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy. World J Gastroenterol. 2017 14;23(2):297-305.
Kim SL, Kim SH, Park YR, Liu YC, Kim EM, Jeong HJ, Kim YN, Seo SY, Kim IH, Lee SO, Lee ST, Kim SW. Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation. Mol Cancer Res. 2017 Feb;15(2):141-151.
Lee HY, Kim SW, Lee GH, Choi MK, Jung HW, Kim YJ, Kwon HJ, Chae HJ. Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation. BMC Complement Altern Med. 2016 26;16(1):316.